HomeHeadlinesUS FDA seeks to accelerate clinical trials of new medicines by using AI to streamline the laborious process of collecting and submitting study dataAPRIL 28, 2026 AT 05:16 PMUS FDA seeks to accelerate clinical trials of new medicines by using AI to streamline the laborious process of collecting and submitting study dataByNewsquawk StaffImportanceLevel 1#FDA#EU SESSION#US SESSION#US EQUITIES#AIExternal
APRIL 28, 2026 AT 05:16 PMUS FDA seeks to accelerate clinical trials of new medicines by using AI to streamline the laborious process of collecting and submitting study dataByNewsquawk StaffImportanceLevel 1#FDA#EU SESSION#US SESSION#US EQUITIES#AIExternal
